CEOs From OpenAI, Anthropic Warn Congress on AI Bioweapons
Top AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesTop AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
A new poll finds a prevailing mood that founders would be disappointed by modern democracy. This sentiment is shaping...
ExxonMobil stock surged January as energy markets moved higher, but the real story runs deeper than a single month. T...
A fresh AI chip IPO in 2026 could redefine how growth looks in semiconductors. This article breaks down why the stock...
Salesforce surged Thursday as the company announced a major debt offering to back a sizable share repurchase plan. Th...
A top China logistics platform generated $1.8 billion in revenue last year, yet one investor cashed out a $6 million ...
Three growth-focused ETFs are drawing fresh attention from analysts who see the potential for triple-digit upside if ...
Geopolitical tensions around Iran and Qatar could reshape global LNG supply. This article explains the potential mark...
Stock splits can create catalysts that spark momentum and attract new buyers. This guide explains how the stock-split...
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
As volatility persists in 2026, investors are turning to best stocks under $20 for value, dividend income, and potent...
Novo Nordisk has drifted toward a five-year low, raising questions about value vs. risk. This guide breaks down the f...